Related Projects

Apo-Decide 

Using systems medicine to deliver personalised medicine for colorectal cancer.

AngioTox 

Histopathologic & Mechanistic Assessment of Angiogenesis Inhibitor Related Toxicities: An EU FP7 Industry-Academia Partnerships & Pathways (IAPP) Funded Project.

MErCuRIC 

A Phase Ib/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients.

OncoTrack

Methods for systematic next generation oncology biomarker development.

Predict Consortium

Personalised RNA Interference to Enhance the Delivery of Individualised Cytotoxic and Targeted therapeutics.

Coloforetell

A Xenopatient Discovery Platform for the integrated Systems based Identification of Predictive Biomarkers for Targeted Therapies in Metastatic Colorectal Cancer